243 related articles for article (PubMed ID: 17824572)
1. Multiple myeloma patient care: treatment options and nursing considerations.
McGee L
ONS Connect; 2007; 22(8 Suppl):67-8. PubMed ID: 17824572
[No Abstract] [Full Text] [Related]
2. Managing patients with multiple myeloma and mantle cell lymphoma: where are we now?
Amen K
ONS Connect; 2007; 22(8 Suppl):63-4. PubMed ID: 17824570
[No Abstract] [Full Text] [Related]
3. Advances in the treatment of MDS, multiple myeloma, and CLL.
Snively A
ONS Connect; 2007; 22(8 Suppl):55-6. PubMed ID: 17824566
[No Abstract] [Full Text] [Related]
4. Clinical updates and nursing considerations for patients with multiple myeloma.
Faiman B
Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma.
Kyle RA; Rajkumar SV
N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
[No Abstract] [Full Text] [Related]
6. Management of novel therapeutics' side effects: a nurse-centric model.
Davies MJ
ONS Connect; 2007; 22(8 Suppl):25-6. PubMed ID: 17824551
[No Abstract] [Full Text] [Related]
7. Advances in the treatment of multiple myeloma: a nursing perspective.
Barrick M
ONS News; 2006; 21(8 Suppl):15-6. PubMed ID: 16925133
[No Abstract] [Full Text] [Related]
8. [Treatment for multiple myeloma: current status and future strategy in Japan].
Iida S
Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
[No Abstract] [Full Text] [Related]
9. [It is not necessary to use novel agents to all patients with newly diagnosed myeloma as an initial therapy].
Takamatsu Y
Rinsho Ketsueki; 2012 Jun; 53(6):587-93. PubMed ID: 22790633
[No Abstract] [Full Text] [Related]
10. [Therapeutic outcomes in systemic lymphatic diseases and plasmacytoma. New hope for palliative patients].
Heinrich B
MMW Fortschr Med; 2005 Jun; 147(24):23. PubMed ID: 16001528
[No Abstract] [Full Text] [Related]
11. Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma.
Tariman JD
Clin J Oncol Nurs; 2007 Aug; 11(4):569-74. PubMed ID: 17723971
[TBL] [Abstract][Full Text] [Related]
12. From the guest editor: the evolving treatment paradigm in multiple myeloma.
Anderson KC
Cancer J; 2009; 15(6):456. PubMed ID: 20010163
[No Abstract] [Full Text] [Related]
13. Myeloma: making sense of a complex blood cancer.
Kelly MB; Meenaghan T; Dowling M
Br J Nurs; 2010 Dec 9-2011 Jan 13; 19(22):1415-21. PubMed ID: 21139523
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma and treatment-related thromboembolism: oncology nurses' role in prevention, assessment, and diagnosis.
Wiley KE
Clin J Oncol Nurs; 2007 Dec; 11(6):847-51. PubMed ID: 18063543
[TBL] [Abstract][Full Text] [Related]
15. New agents and approaches in the treatment of multiple myeloma.
Anderson KC
Clin Adv Hematol Oncol; 2003 Mar; 1(3):151-2. PubMed ID: 16224394
[No Abstract] [Full Text] [Related]
16. Current status of new drugs for the treatment of patients with multiple myeloma.
Kenealy M; Prince HM
Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741
[TBL] [Abstract][Full Text] [Related]
17. Advances in oral therapy in the treatment of multiple myeloma.
Doss DS
Clin J Oncol Nurs; 2006 Aug; 10(4):514-20. PubMed ID: 16927905
[TBL] [Abstract][Full Text] [Related]
18. Advancing access to myeloma treatment: administration, side effects, and implications for survival.
Davies MJ
ONS News; 2006; 21(8 Suppl):11-2. PubMed ID: 16925131
[No Abstract] [Full Text] [Related]
19. Multiple myeloma - current issues and controversies.
Kumar S
Cancer Treat Rev; 2010 May; 36 Suppl 2():S3-11. PubMed ID: 20472186
[TBL] [Abstract][Full Text] [Related]
20. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
Kettle JK; Finkbiner KL; Klenke SE; Baker RD; Henry DW; Williams CB
J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
